Back to Search
NIMA SHARIFI, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1730820077Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
MT231517(PA)
Research & Publications (20)
Targeted chemotherapy: chronic myelogenous leukemia as a model.
PMID 11976731·J Mol Med (Berl)·2002
6-review
The genetics of castration-resistant prostate cancer: what can the germline tell us?
PMID 18676736·Clin Cancer Res·2008
6-review
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer.
PMID 18537956·BJU Int·2008
8-other
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.
PMID 18519758·Clin Cancer Res·2008
7-preclinical
Frequency of Epstein-Barr virus expression in various histological subtypes of Hodgkin's lymphoma.
PMID 18439160·Histopathology·2008
8-other
Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)".
PMID 18344511·Am J Epidemiol·2008
8-other
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
PMID 18075739·Cancer Chemother Pharmacol·2008
8-other
Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma.
PMID 18231912·Leuk Lymphoma·2008
8-other
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
PMID 18829485·Clin Cancer Res·2008
8-other
Secondary hormonal therapy for prostate cancer: what lies on the horizon?
PMID 17922868·BJU Int·2008
6-review
Androgen receptor modulation: lessons learned from beyond the prostate.
PMID 17881894·Cancer Biol Ther·2007
6-review
Screening for prostate cancer: current status and future prospects.
PMID 17765037·Am J Med·2007
8-other
A bifunctional colchicinoid that binds to the androgen receptor.
PMID 17699728·Mol Cancer Ther·2007
8-other
Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia.
PMID 17381506·Diabet Med·2007
8-other
Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?
PMID 17975259·J Mol Endocrinol·2007
8-other
Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.
PMID 17143354·Saudi Med J·2006
8-other
Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.
PMID 16855379·Cancer Biol Ther·2006
6-review
Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation?
PMID 16364563·Med Hypotheses·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- LVPG ENDOCRINOLOGY 1243 S. CEDAR CREST BLVD, SUITE 2800
ALLENTOWN, PA 18103 - Phone
- (833) 363-6274
Quick Facts
- NPI
- 1730820077
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile